MNNGF (Baijin Life Science Holdings) Beneish M-Score: -0.70 (As of Jun. 25, 2026)


MNNGF Baijin Life Science Holdings Ltd MNNGF
35 GF Score
Price $0.08
GF Value $0.04
! 6 Warning Signs
View Full Analysis

What is Baijin Life Science Holdings Beneish M-Score?

Baijin Life Science Holdings MNNGF 35 Beneish M-Score is -0.70 as of Jun. 25, 2026. GuruFocus rates MNNGF with a GF Score™ of 35/100 and a GF Value™ of $0.04. The stock has 6 warning signs investors should review. Among 1,087 Retail - Cyclical companies, Baijin Life Science Holdings ranks worse than 91.54% on this metric.

The zones of discrimination for M-Score is as such:

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator.
An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Warning Sign:

Beneish M-Score -0.7 higher than -1.78, which implies that the company might have manipulated its financial results.

The historical rank and industry rank for Baijin Life Science Holdings's Beneish M-Score or its related term are showing as below:

MNNGF' s Beneish M-Score Range Over the Past 10 Years
Min: -10.47   Med: -2.78   Max: 0.4
Current: -0.7

During the past 12 years, the highest Beneish M-Score of Baijin Life Science Holdings was 0.40. The lowest was -10.47. And the median was -2.78.


Baijin Life Science Holdings Beneish M-Score Historical Data

* Premium members only.

The historical data trend for Baijin Life Science Holdings's Beneish M-Score can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Baijin Life Science Holdings Beneish M-Score Chart

Baijin Life Science Holdings Annual Data
Trend Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25
Beneish M-Score
Get a 7-Day Free Trial Premium Member Only Premium Member Only -6.10 0.00 0.00 0.00 -0.70

Baijin Life Science Holdings Semi-Annual Data
Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24 Sep24 Mar25 Sep25
Beneish M-Score Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 -0.70 0.00

MNNGF vs TPR: Beneish M-Score Comparison

For the Luxury Goods subindustry, Baijin Life Science Holdings's Beneish M-Score, along with its competitors' market caps and Beneish M-Score data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Baijin Life Science Holdings Beneish M-Score vs Retail - Cyclical Industry

For the Retail - Cyclical industry and Consumer Cyclical sector, Baijin Life Science Holdings's Beneish M-Score distribution charts can be found below:

* The bar in red indicates where Baijin Life Science Holdings's Beneish M-Score falls into.


MNNGF
35GF Score
Baijin Life Science Holdings Ltd MNNGF
Beneish M-Score is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Baijin Life Science Holdings Beneish M-Score Calculation

The M-score was created by Professor Messod Beneish. Instead of measuring the bankruptcy risk (Altman Z-Score) or business trend (Piotroski F-Score), M-score can be used to detect the risk of earnings manipulation. This is the original research paper on M-score.

The M-Score Variables:

The M-score of Baijin Life Science Holdings for today is based on a combination of the following eight different indices:

M=-4.84+0.92 * DSRI+0.528 * GMI+0.404 * AQI+0.892 * SGI+0.115 * DEPI
=-4.84+0.92 * 1.0996+0.528 * 1.0888+0.404 * 0.4711+0.892 * 2.5419+0.115 * 0.6362
-0.172 * SGAI+4.679 * TATA-0.327 * LVGI
-0.172 * 0.5173+4.679 * 0.104093-0.327 * 1.0966
=-0.68

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

This Year (Mar25) TTM:Last Year (Mar24) TTM:
Total Receivables was $13.97 Mil.
Revenue was $17.44 Mil.
Gross Profit was $5.40 Mil.
Total Current Assets was $29.20 Mil.
Total Assets was $37.33 Mil.
Property, Plant and Equipment(Net PPE) was $2.17 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.86 Mil.
Selling, General, & Admin. Expense(SGA) was $4.80 Mil.
Total Current Liabilities was $6.40 Mil.
Long-Term Debt & Capital Lease Obligation was $10.59 Mil.
Net Income was $-0.04 Mil.
Gross Profit was $0.00 Mil.
Cash Flow from Operations was $-3.93 Mil.
Total Receivables was $5.00 Mil.
Revenue was $6.86 Mil.
Gross Profit was $2.31 Mil.
Total Current Assets was $15.51 Mil.
Total Assets was $25.16 Mil.
Property, Plant and Equipment(Net PPE) was $1.12 Mil.
Depreciation, Depletion and Amortization(DDA) was $0.25 Mil.
Selling, General, & Admin. Expense(SGA) was $3.65 Mil.
Total Current Liabilities was $5.24 Mil.
Long-Term Debt & Capital Lease Obligation was $5.20 Mil.




1. DSRI = Days Sales in Receivables Index

Measured as the ratio of Revenue in Total Receivables in year t to year t-1.

A large increase in DSR could be indicative of revenue inflation.

DSRI=(Receivables_t / Revenue_t) / (Receivables_t-1 / Revenue_t-1)
=(13.97 / 17.44) / (4.998 / 6.861)
=0.801032 / 0.728465
=1.0996

2. GMI = Gross Margin Index

Measured as the ratio of gross margin in year t-1 to gross margin in year t.

Gross margin has deteriorated when this index is above 1. A firm with poorer prospects is more likely to manipulate earnings.

GMI=GrossMargin_t-1 / GrossMargin_t
=(GrossProfit_t-1 / Revenue_t-1) / (GrossProfit_t / Revenue_t)
=(2.314 / 6.861) / (5.402 / 17.44)
=0.337269 / 0.309748
=1.0888

3. AQI = Asset Quality Index

AQI is the ratio of asset quality in year t to year t-1.

Asset quality is measured as the ratio of non-current assets other than Property, Plant and Equipment to Total Assets.

AQI=(1 - (CurrentAssets_t + PPE_t) / TotalAssets_t) / (1 - (CurrentAssets_t-1 + PPE_t-1) / TotalAssets_t-1)
=(1 - (29.204 + 2.167) / 37.332) / (1 - (15.508 + 1.123) / 25.157)
=0.159675 / 0.338912
=0.4711

4. SGI = Sales Growth Index

Ratio of Revenue in year t to sales in year t-1.

Sales growth is not itself a measure of manipulation. However, growth companies are likely to find themselves under pressure to manipulate in order to keep up appearances.

SGI=Sales_t / Sales_t-1
=Revenue_t / Revenue_t-1
=17.44 / 6.861
=2.5419

5. DEPI = Depreciation Index

Measured as the ratio of the rate of Depreciation, Depletion and Amortization in year t-1 to the corresponding rate in year t.

DEPI greater than 1 indicates that assets are being depreciated at a slower rate. This suggests that the firm might be revising useful asset life assumptions upwards, or adopting a new method that is income friendly.

DEPI=(Depreciation_t-1 / (Depreciaton_t-1 + PPE_t-1)) / (Depreciation_t / (Depreciaton_t + PPE_t))
=(0.247 / (0.247 + 1.123)) / (0.857 / (0.857 + 2.167))
=0.180292 / 0.283399
=0.6362

Note: If the Depreciation, Depletion and Amortization data is not available, we assume that the depreciation rate is constant and set the Depreciation Index to 1.

6. SGAI = Sales, General and Administrative expenses Index

The ratio of Selling, General, & Admin. Expense(SGA) to Sales in year t relative to year t-1.

SGA expenses index > 1 means that the company is becoming less efficient in generate sales.

SGAI=(SGA_t / Sales_t) / (SGA_t-1 /Sales_t-1)
=(4.801 / 17.44) / (3.651 / 6.861)
=0.275287 / 0.532138
=0.5173

7. LVGI = Leverage Index

The ratio of total debt to Total Assets in year t relative to yeat t-1.

An LVGI > 1 indicates an increase in leverage

LVGI=((LTD_t + CurrentLiabilities_t) / TotalAssets_t) / ((LTD_t-1 + CurrentLiabilities_t-1) / TotalAssets_t-1)
=((10.587 + 6.397) / 37.332) / ((5.197 + 5.24) / 25.157)
=0.454945 / 0.414875
=1.0966

8. TATA = Total Accruals to Total Assets

Total accruals calculated as the change in working capital accounts other than cash less depreciation.

TATA=(IncomefromContinuingOperations_t - CashFlowsfromOperations_t) / TotalAssets_t
=(NetIncome_t - NonOperatingIncome_t - CashFlowsfromOperations_t) / TotalAssets_t
=(-0.041 - 0 - -3.927) / 37.332
=0.104093

An M-Score of equal or less than -1.78 suggests that the company is unlikely to be a manipulator. An M-Score of greater than -1.78 signals that the company is likely to be a manipulator.

Baijin Life Science Holdings has a M-score of -0.68 signals that the company is likely to be a manipulator.

Frequently Asked Questions Learn more about Beneish M-Score →
What does a Beneish M-Score of -0.70 mean?
Baijin Life Science Holdings (MNNGF) has a Beneish M-Score of -0.70 as of Jun. 25, 2026. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Baijin Life Science Holdings and its competitors. According to the industry distribution chart, Baijin Life Science Holdings ranks #995 out of 1087 companies in the Retail - Cyclical industry, placing it in the top 91.5%.
Is Baijin Life Science Holdings' Beneish M-Score too high?
Baijin Life Science Holdings' current Beneish M-Score is -0.70. Based on the distribution chart, Baijin Life Science Holdings ranks #995 out of 1087 companies in the Retail - Cyclical industry, which is in the bottom quartile relative to peers. Overall, Baijin Life Science Holdings has a GF Score™ of 35/100, reflecting its overall financial health beyond just this single metric.
How does Baijin Life Science Holdings' Beneish M-Score compare to TPR?
According to the Retail - Cyclical industry distribution chart, Baijin Life Science Holdings ranks #995 out of 1087 companies for Beneish M-Score. This places Baijin Life Science Holdings in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Beneish M-Score for a Retail - Cyclical company?
A good Beneish M-Score depends on the Retail - Cyclical industry context. However, Beneish M-Score should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Beneish M-Score mean?
A high Beneish M-Score can signal that a stock is expensive relative to its fundamentals. The Beneish M-score measures the likelihood of earnings manipulation. View historical data on Baijin Life Science Holdings and its competitors. Baijin Life Science Holdings's current Beneish M-Score is -0.70. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Baijin Life Science Holdings stock overvalued right now?
Baijin Life Science Holdings (MNNGF) has a current Beneish M-Score of -0.70. The stock's GF Value™ is $0.04, compared to a current price of $0.08 — trading 87.5% above its estimated fair value. The current Beneish M-Score is -0.70. Baijin Life Science Holdings' overall GF Score™ is 35/100 with 6 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Beneish M-Score calculated?
Beneish M-Score is calculated from a company's financial statements. For Baijin Life Science Holdings (MNNGF), the current Beneish M-Score is -0.70 as of Jun. 25, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Baijin Life Science Holdings (MNNGF) Overvalued in 2026?

Based on GuruFocus' analysis, Baijin Life Science Holdings stock appears to be overvalued. The current stock price of $0.08 is trading 87.5% above its estimated GF Value™ of $0.04.

Key valuation signals for MNNGF:

  • Beneish M-Score: -0.70
  • GF Value™: $0.04 vs. price of $0.08 (87.5% above fair value)
  • GF Score™: 35/100 with 6 warning signs

No single metric tells the full story. See the MNNGF stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.


Baijin Life Science Holdings Business Description

Other Exchanges 01466:Hong Kong
Address 66 Gloucester Road, Office B, 9/F Pico Tower, Wanchai, Hong Kong, HKG
Baijin Life Science Holdings Ltd is positioned as a biopharmaceutical company dedicated in anti-aging and preventive medicine, as well as cellular precision therapy. The company has three business segment: jewelry business segment; strategic investment segment; and skincare business segment. The majority of revenue is coming from jewelry business segment.
35GF Score

Get the complete analysis for MNNGF

Beneish M-Score is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$0.08
Price
$0.04
GF Value